|
|
Company Name
|
DeciZen
|
Market cap
(Rs. Cr.) |
CMP
(Change %) |
Latest
P/E |
Latest
P/BV |
5Y Sales
Gr.(%) |
5Y Profit
Gr.(%) |
|
|---|---|---|---|---|---|---|---|---|---|
| 31 |
Q
V
PT
|
14,527 Small Cap |
1,458.95 (2.00%) |
59.04 | 8.53 | 20.26 | 35.07 |
|
|
| 32 |
Q
V
PT
|
32,838 Small Cap |
768.05 (-1.77%) |
120.19 | 8.07 | 12.78 | 6.32 |
|
|
| 33 |
Q
V
PT
|
37,104 Mid Cap |
1,860.95 (2.50%) |
46.6 | 8.01 | 25.04 | 0.00 |
|
|
| 34 |
Q
V
PT
|
16,417 Small Cap |
1,541.20 (-1.79%) |
58.55 | 7.78 | 11.33 | 1.26 |
|
|
| 35 |
Q
V
PT
|
15,843 Small Cap |
497.20 (-0.51%) |
106.24 | 7.58 | 26.38 | 0.00 |
|
|
| 36 |
Q
V
PT
|
11,544 Small Cap |
562.95 (1.13%) |
57.9 | 7.49 | 10.52 | 0.55 |
|
|
| 37 |
Q
V+
PT
|
68,218 Mid Cap |
916.85 (1.47%) |
305.94 | 7.46 | 23.15 | 0.00 |
|
|
| 38 |
Q
V+
PT
|
6,981 Small Cap |
687.25 (-1.00%) |
N/A | 7.16 | 0.00 | 0.00 |
|
|
| 39 |
Q
V
PT
|
2,597 Small Cap |
5,369.45 (-0.08%) |
34.05 | 7.02 | 27.49 | 0.00 |
|
|
| 40 |
Q
V+
PT
|
4,357 Small Cap |
2,579.95 (-2.07%) |
35.72 | 6.71 | 12.70 | 21.72 |
|
|
| 41 |
Q
V+
PT
|
10,827 Small Cap |
718.40 (-0.94%) |
641.88 | 6.66 | 13.15 | 0.00 |
|
|
| 42 |
Q
V+
PT
|
10,523 Small Cap |
370.20 (-0.59%) |
N/A | 6.62 | -12.01 | 0.00 |
|
|
| 43 |
Q
V
PT
|
6,244 Small Cap |
1,061.90 (-2.67%) |
62.84 | 6.61 | 25.90 | 14.68 |
|
|
| 44 |
Q
V
PT
|
1,699 Small Cap |
323.75 (-0.74%) |
47.1 | 6.54 | 9.86 | -51.00 |
|
|
| 45 |
Q
V+
PT
|
927 Small Cap |
269.05 (1.49%) |
16.83 | 6.37 | 10.29 | 30.27 |
|
|
| 46 |
Q
V+
PT
|
1,555 Small Cap |
239.75 (1.63%) |
34.76 | 6.3 | 11.13 | 39.15 |
|
|
| 47 |
Q
V+
PT
|
14,003 Small Cap |
902.80 (2.69%) |
622.51 | 6.25 | -37.26 | -34.46 |
|
|
| 48 |
Q
V+
PT
|
15,930 Small Cap |
856.30 (5.13%) |
56.33 | 6.23 | 11.30 | 12.66 |
|
|
| 49 |
Q
V
PT
|
2,651 Small Cap |
36.64 (-3.43%) |
N/A | 6.21 | 96.10 | 0.00 |
|
|
| 50 |
Q
V+
PT
|
65,081 Mid Cap |
2,386.60 (3.50%) |
37.46 | 6.14 | 9.19 | 22.19 |
|
|
| 51 |
Q
V+
PT
|
30,643 Small Cap |
1,899.85 (0.75%) |
75.48 | 6.13 | 4.49 | 0.00 |
|
|
| 52 |
Q
V
PT
|
10,146 Small Cap |
307.50 (-0.65%) |
54.41 | 6.13 | 21.03 | 54.33 |
|
|
| 53 |
Q
V
PT
|
4,341 Small Cap |
417.95 (-3.45%) |
57 | 6.1 | 14.04 | 7.05 |
|
|
| 54 |
Q
V+
PT
|
2,818 Small Cap |
615.30 (-2.41%) |
34.52 | 5.84 | 14.27 | 28.52 |
|
|
| 55 |
Q
V+
PT
|
48,469 Mid Cap |
1,921.30 (0.57%) |
39.19 | 5.84 | 7.35 | 1.36 |
|
|
| 56 |
Q
V
PT
|
97,963 Mid Cap |
2,375 (0.13%) |
44.98 | 5.8 | 13.54 | 13.36 |
|
|
| 57 |
Q
V+
PT
|
5,164 Small Cap |
328.55 (0.72%) |
46 | 5.77 | 21.41 | 79.02 |
|
|
| 58 |
Q
V
PT
|
17,411 Small Cap |
1,737.95 (1.18%) |
52.4 | 5.62 | 17.34 | 19.17 |
|
|
| 59 |
Q
V
PT
|
8,233 Small Cap |
909 (6.38%) |
90.8 | 5.32 | 27.90 | 137.67 |
|
|
| 60 |
Q
V+
PT
|
4,56,090 Large Cap |
1,909.90 (0.47%) |
37.89 | 5.3 | 11.78 | 14.41 |
|
|
Pharma - Today's Top Gainers
| Company Name | CMP | Price Change(%) |
|---|---|---|
| 120.80 | 13.96% | |
| 411.40 | 8.01% | |
| 17.21 | 6.63% | |
| 909 | 6.38% | |
| 1,510.40 | 6.11% |
Pharma - Today's Top Losers
| Company Name | CMP | Price Change(%) |
|---|---|---|
| 417.95 | -3.45% | |
| 36.64 | -3.43% | |
| 564.10 | -3.12% | |
| 509.40 | -3.12% | |
| 449.05 | -2.93% |
| Rank | Company | Market Capitalization 2026 (INR crores) |
|---|---|---|
| 1 | Sanofi Consumer Healthcare India Ltd. | 9,715 Crore |
| 2 | Rubicon Research Ltd. | 28,558 Crore |
| 3 | Torrent Pharmaceuticals Ltd. | 1,85,639 Crore |
| 4 | Astrazeneca Pharma India Ltd. | 18,526 Crore |
| 5 | Glaxosmithkline Pharmaceuticals Ltd. | 49,121 Crore |
| 6 | Laurus Labs Ltd. | 98,048 Crore |
| 7 | CORONA Remedies Ltd. | 13,088 Crore |
| 8 | Procter & Gamble Health Ltd. | 9,685 Crore |
| 9 | Anthem Biosciences Ltd. | 49,101 Crore |
| 10 | Vijaya Diagnostic Centre Ltd. | 15,486 Crore |
You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.
Based on ROE, the best stocks in the Nifty Pharma companies index are:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | ROE |
|---|---|---|---|---|---|---|---|
| Abbott India Ltd. (M) | Very Good | 26,416 | 55,770 | 34.54 | 10.77 | 23.68 | 34.24 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,861 | 1,85,639 | 85.12 | 20.68 | 38.91 | 29.04 |
| Glenmark Pharmaceuticals Ltd. (M) | Very Good | 2,387 | 65,081 | 36.20 | 5.94 | 12.07 | 27.89 |
| Lupin Ltd. (M) | Somewhat Good | 2,190 | 1,00,272 | 18.14 | 4.21 | 10.04 | 26.43 |
| Ajanta Pharma Ltd. (M) | Very Good | 3,575 | 45,489 | 40.08 | 9.36 | 27.08 | 25.35 |
Based on the past year's gain, the best performing stocks are:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | Yearly gain (%) |
|---|---|---|---|---|
| Laurus Labs Ltd. (M) | Very Good | 1,796 | 98,048 | 104 |
| Sai Life Sciences Ltd. (S) | Very Good | 1,436 | 30,920 | 55.25 |
| Aurobindo Pharma Ltd. (M) | Very Good | 1,610 | 93,208 | 53.26 |
| Gland Pharma Ltd. (S) | Very Good | 2,802 | 46,527 | 43.08 |
| Divis Laboratories Ltd. (L) | Very Good | 8,500 | 2,26,976 | 38.20 |
| View More |
Stocks with the highest revenue growth in the past 5 years is:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | 5Y Sales Growth (%) |
|---|---|---|---|---|---|---|---|
| Sai Life Sciences Ltd. (S) | Very Good | 1,436 | 30,920 | 87.23 | 11.99 | 46.16 | 17.75 |
| Ajanta Pharma Ltd. (M) | Very Good | 3,575 | 45,489 | 40.08 | 9.36 | 27.08 | 13.54 |
| Mankind Pharma Ltd. (M) | Very Good | 2,375 | 97,963 | 44.93 | 5.79 | 28.53 | 13.54 |
| Zydus Lifesciences Ltd. (M) | Very Good | 1,101 | 1,11,720 | 24.76 | 4.14 | 13.91 | 13.52 |
| Lupin Ltd. (M) | Somewhat Good | 2,190 | 1,00,272 | 18.14 | 4.21 | 10.04 | 13.02 |
Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.
Stocks with the highest profit growth in the past 5 years is:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | 5Y Profit Growth (%) |
|---|---|---|---|---|---|---|---|
| Lupin Ltd. (M) | Somewhat Good | 2,190 | 1,00,272 | 18.14 | 4.21 | 10.04 | 32.37 |
| Glenmark Pharmaceuticals Ltd. (M) | Very Good | 2,387 | 65,081 | 36.20 | 5.94 | 12.07 | 22.19 |
| Abbott India Ltd. (M) | Very Good | 26,416 | 55,770 | 34.54 | 10.77 | 23.68 | 17.33 |
| Dr. Reddys Laboratories Ltd. (M) | Very Good | 1,195 | 98,074 | 30.44 | 2.57 | 15.61 | 15.75 |
| Zydus Lifesciences Ltd. (M) | Very Good | 1,101 | 1,11,720 | 24.76 | 4.14 | 13.91 | 14.72 |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through:
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
|
Name of the IA registered
with SEBI: |
The Alchemists Ark Pvt. Ltd. |
|
Logo:
|
|
|
Trade/Brand
Name of IA: |
MoneyWorks4Me Investment Advisers |
|
Brand Logo:
|
 |
|
SEBI Registration Number:
|
INA000013323 Validity – May 16, 2019 – Perpetual |
|
Registration:
|
Non-Individual |
|
BSE Enlistment No:
|
1187 |
|
Address:
|
B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045 |
|
Compliance Officer
Details: |
Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com |
Telephone: +919860359463 Address: Same as IA |
|
Grievance Officer
Details: |
Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com |
Telephone: +919860919463 Address: Same as IA |
|
Principal Officer
Details: |
Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com |
Telephone: +919175899463 Address: Same as IA |
|
Standard Warning:
|
Investment in securities market are subject to market risks. Read all the related documents carefully before investing. |
|
|
Disclaimer:
|
Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. |
|
